Trial Profile
Overall assessment of improvement in bronchial asthma patients with extraesophageal reflux after effective acid suppression.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Jul 2011
Price :
$35
*
At a glance
- Drugs Rabeprazole (Primary)
- Indications Asthma; Gastro-oesophageal reflux
- Focus Therapeutic Use
- 21 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Nov 2005 New trial record.